Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Author Bio
James Mickleboro is an investment writer and analyst who has worked with The Motley Fool Australia for 10 years, covering ASX shares, market news, broker research, dividends, growth stocks, and long-term investing ideas.
Over that time, James has written extensively about Australian equities and developed a particular focus on helping everyday investors understand the stories behind share price moves, company announcements, broker views, and broader market trends.
His best investment recommendation was identifying Afterpay while it was still a small-cap growth share, before its rise into one of Australia’s biggest technology success stories. His worst investment lesson came from CSL Ltd (ASX: CSL), where he was burnt by believing management could turn the business around sooner than the market ultimately allowed.
Areas of Expertise
ASX shares
Growth and dividend investing
Broker research
Interpreting company announcements
Market news
Portfolio strategy
Long-term wealth creation
Education
Bachelor of Politics, Philosophy and Economics. CFA Institute
Social Media
LinkedInFavorite Investment Quote
"It’s far better to buy a wonderful company at a fair price than a fair company at a wonderful price."
— Warren Buffett
Broker sees potential upside of 43% from current levels
Citi suspects that no trading update means Appen will hit its guidance in FY 2021
The Appen Ltd(ASX: APX) share price has been a strong performer on Tuesday.
In morning trade, the artificial intelligence data services company's shares are up 5% to $10.32.
Why is the Appen share price pushing higher today?
The catalyst for the rise in the Appen share price on Tuesday has been a broker note out of Citi.
According to the note, the broker has retained its buy rating on the company's shares and added them to its positive catalyst watch.
And although the broker has cut its price target by over 13% to $14.80, this still suggests material upside of 43% over the next 12 months based on the current Appen share price.
Why is the broker positive?
Today's recommendation essentially comes down to the proverb: "No news is good news."
Citi notes that Appen has not released a trading update in relation to its performance during FY 2021, which ended on 31 December.
Given that it has provided guidance for earnings before interest, tax, depreciation and amortisation (EBITDA) to be at the low end of $81 million to $88 million in FY 2021, the lack of update appears to be an indication that it has performed in line with expectations.
After all, the company would be obliged to update the market if it found that its results differed materially to its guidance. This is exactly what it did in the middle of December 2020 when it realised that its FY 2020 results were going to fall short of guidance.
All in all, Citi suspects there could be upside risk to consensus estimates.
What now?
Unless Appen surprises with a trading update in the second half of January, the next time we'll hear from the company is on 24 February when it releases its eagerly anticipated full year results.
Though, arguably it will be what management says about FY 2022 that could have the greatest impact on the Appen share price. Especially with some brokers speculating that big tech companies are bypassing Appen and taking their data annotation services in-house.
